Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Indian Pediatrics|January 16, 2021
Outcome of Children Admitted With SARS-CoV-2 Infection: Experiences From a Pediatric Public HospitalSudha Rao, Vrushabh Gavali, Shakuntala S Prabhu, et al.Immunologic Research|May 18, 2023
Monogenic inborn errors of immunity in autoimmune disordersIyengar Vaishnavi Venkatachari, Akshaya Chougule, Vijaya Gowri, et al.Journal of Indian Association of Pediatric Surgeons|June 18, 2026
Limitations of Functional Scoring Systems in Predicting Long-term Quality of Life in Anorectal MalformationsAdwait S Bendre, Arka Banerjee, Rishabh A Jain, et al.International Journal of Rheumatic Diseases|July 15, 2023
Cleavage-resistant RIPK1-induced autoinflammatory syndrome-A report of three generations with periodic fever and clinical response to colchicineAkshaya Chougule, Vaishnavi V Iyengar, Vijaya Gowri, et al.Thrombosis Journal|March 14, 2023
Narsoplimab for severe transplant-associated thrombotic microangiopathyAmbreen Pandrowala, Parth Ganatra, V P Krishnan, et al.Frontiers in Immunology|October 27, 2025
Tregopathy in focusVaishnavi Venkatachari Iyengar, Vijaya Gowri, Akshaya Sanjay Chougule, et al.Lung India : Official Organ of Indian Chest Society|December 31, 2025
Safety and outcome of bedaquiline and delamanid-based longer oral regimen in Indian children less than 5 years with drug-resistant tuberculosisIra Shah, Ramsha Ansari, Dhruv N Gandhi, et al.The Pediatric Infectious Disease Journal|February 14, 2022
Feasibility of a "Salvage Regimen" Using Home-based Intravenous Meropenem Therapy With a Delamanid/Bedaquilline Containing Regimen in the Management of MDR/XDR Pediatric TuberculosisIra Shah, Sonu Antony, Akanksha Jaiswal, et al.Scientific Reports|January 10, 2024
The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocolAmbreen Pandrowala, Sanna Khan, Darshan Kataria, et al.Lung India : Official Organ of Indian Chest Society|June 26, 2025
Treatment outcomes of bedaquiline-based longer oral antitubercular regimens in Indian children above five years of ageIra Shah, Dhruv N Gandhi, Ramsha Ansari, et al.Pageof 4